发明名称 Bioassay for the early detection of autoimmune diseases
摘要 Provided are methods for aiding in diagnosing autoimmune diseases in a mammal, comprising contacting a biological sample that is not a tear sample from the mammal with an antibody that specifically binds to a first polypeptide selected from the group Ctss, Ctsh, Ctsr, Ctsw, Ctsz, Ifng, IL-6ra, IL-10, IL-10ra, IL-15, Tnfa, Apo-F, or Lcn-2 or a second polypeptide selected from the group lactoperoxidase, lactoferrin or lysozyme under conditions favoring the formation of an antibody-polypeptide complex, and determining the amount of complex formed, wherein an increased formation of antibody-first-polypeptide complex or a decreased formation of antibody-second-polypeptide complex as compared to a suitable control, indicates a likely positive diagnosis of an autoimmune disease for the mammal, thereby aiding in the diagnosis. Methods of treating the autoimmune diseases are also provided.
申请公布号 US9606117(B2) 申请公布日期 2017.03.28
申请号 US201113324963 申请日期 2011.12.13
申请人 University of Southern California 发明人 Hamm-Alvarez Sarah
分类号 G01N33/53;G01N33/564;A61K38/13;A61K31/4178;A61K31/46;A61K31/56 主分类号 G01N33/53
代理机构 Foley & Lardner LLP 代理人 Foley & Lardner LLP ;Konski Antoinette F.
主权项 1. A method for detecting a polypeptide in a mammal likely to develop lupus or Sjogren's Syndrome, the method comprising the steps of: measuring an expression level of the polypeptide selected from the group consisting of cathepsin S (Ctss), cathepsin H (Ctsh), cathepsin R (Ctsr), cathepsin W (Ctsw) or cathepsin Z (Ctsz) by contacting a sample selected from the group consisting of saliva, plasma, blood, spinal fluid or lymphatic drainage with a Schirmer's test strip embedded with a quantitative fluorometric antibody specific for the polypeptide and measuring the amount of antibody bound to the polypeptide.
地址 Los Angeles CA US